Kimberley Mental Health and Drug Service, Broome, Australia.
Pharmacol Ther. 2012 Apr;134(1):116-24. doi: 10.1016/j.pharmthera.2012.01.006. Epub 2012 Jan 20.
Brain Derived Neurotrophic Factor (BDNF) is a unique member of the neurotrophin family with potent and plethoric effects on the proliferation, differentiation, survival and death of neuronal and non-neuronal cells, thereby making it critical in the health and well being of the nervous system. Studies of various neurological and psychiatric disorders implicate BDNF aberration as a predisposing and perpetuating factor with predictive utility in treatment outcomes. BDNF therapies have yielded good results in animal models of disease states and studies in human subjects are underway. BDNF may be the "missing-link" that mediates the interaction between gene and environment, synaptic plasticity and apoptosis and transgenerational transmission of disease vulnerability. There is theoretical and empirical support for a model in which BDNF underpins the integrity of the central nervous system and this may herald a quantum leap in the way we approach disorders of the mind and brain. Understanding and developing therapies centered on the role of BDNF may lead to paradigm shifts in current practice and treatment of psychiatric and neurological disorders.
脑源性神经营养因子(BDNF)是神经生长因子家族中的一个独特成员,对神经元和非神经元细胞的增殖、分化、存活和死亡具有强大而丰富的作用,因此对神经系统的健康和福祉至关重要。对各种神经和精神疾病的研究表明,BDNF 异常是一种易患和持续的因素,对治疗结果具有预测作用。BDNF 疗法在疾病动物模型中取得了良好的效果,人类研究也正在进行中。BDNF 可能是“缺失的环节”,介导基因与环境、突触可塑性和细胞凋亡以及疾病易感性的跨代传递之间的相互作用。有理论和经验支持这样一种模型,即 BDNF 是中枢神经系统完整性的基础,这可能预示着我们在处理精神和大脑障碍的方式上发生了巨大飞跃。理解和开发以 BDNF 为中心的治疗方法可能会导致当前精神和神经疾病的实践和治疗范式的转变。